Big Pharma Is Turning to China for the Newest Drug Ideas
(feeds.content.dowjones.io)
31.
32.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
33.
Peptides: where to begin?
(news.ycombinator.com)
34.
AI is coming for superbugs
(feeds.feedburner.com)
35.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
36.
Why the US needs a unified, mission-based strategy for health innovation
(feeds.nature.com)
37.
38.
39.
40.
41.
Scientists Intrigued by Microbe That That Makes Mice Swole
(futurism.com)
42.
Novartis to Buy Biotech Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
43.
Antibiotic resistance among germs swells during droughts, study suggests
(arstechnica.com)
44.
45.
The most innovative biotech companies of 2026
(feeds.feedburner.com)
46.
Lab-grown oesophagus restores pigs’ ability to swallow
(feeds.nature.com)
47.
A single course of antibiotics can cause lingering changes in gut microbes
(feeds.nature.com)
48.
The real story behind China’s technology triumph
(feeds.nature.com)
49.
Opinion | India’s Boundless Biotech Potential
(feeds.content.dowjones.io)
50.
BioNTech Shares Fall After Co-Founders Plan Exit and Outlook Misses Forecasts
(feeds.content.dowjones.io)
51.
The yoghurt delivery women combatting loneliness in Japan
(news.ycombinator.com)
53.
The scientist using AI to hunt for antibiotics just about everywhere
(technologyreview.com)
54.
China’s biotech boom: why the nation must collaborate to stay ahead
(feeds.nature.com)
55.
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
(feeds.content.dowjones.io)
56.
Show HN: BioTradingArena – Benchmark for LLMs to predict biotech stock movements
(news.ycombinator.com)
57.
Merck No Longer in Talks to Buy Revolution Medicines
(feeds.content.dowjones.io)
58.
Opinion | America Is Losing the Biotech Fight to China
(feeds.content.dowjones.io)
60.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)